Clarithromycin Resistance and Susceptibility Patterns of Mycobacterium avium Strains Isolated During Prophylaxis for Disseminated Infection in Patients with AIDS
A randomized, placebo-controlled trial was conducted to evaluate the efficacy of clarithromycin in the prevention of disseminated Mycobacterium avium complex (MAC) infection in patients with AIDS; special attention was given to the development of clarithromycin resistance. The median time to documen...
Saved in:
Published in | Clinical infectious diseases Vol. 27; no. 4; pp. 807 - 812 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
United States
The University of Chicago Press
01.10.1998
University of Chicago Press |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | A randomized, placebo-controlled trial was conducted to evaluate the efficacy of clarithromycin in the prevention of disseminated Mycobacterium avium complex (MAC) infection in patients with AIDS; special attention was given to the development of clarithromycin resistance. The median time to documented MAC bacteremia was 199 days for placebo-treated patients, 217 days for clarithromycin-treated patients infected with clarithromycin-susceptible MAC, and 385 days for clarithromycin-treated patients infected with clarithromycin-resistant MAC. Most of the patients with clarithromycin-resistant isolates (91%) had a baseline CD4 T-cell count of <20/μL, while these low counts occurred in only 25% of patients having clarithromycin-susceptible breakthrough isolates. The emergence of clarithromycin resistance did not affect the total period of survival. Resistance to clarithromycin in breakthrough MAC isolates emerges most likely when the patient is extremely immunodeficient at the time of initiation of the preventative therapy. |
---|---|
Bibliography: | istex:93F73B7D66BC9BD5B54C4A89DF3FF575E56F0352 ark:/67375/HXZ-C2HPV3QK-L Reprints or correspondence: Dr. J Carl Craft, Venture Head, Abbott Laboratories, AP-34, 200 Abbott Park Road, Abbott Park, Illinois 60064. ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-News-3 |
ISSN: | 1058-4838 1537-6591 |
DOI: | 10.1086/514961 |